Safety and efficacy of flow re-direction endoluminal device (FRED) in the treatment of cerebral aneurysms: a single center experience

被引：34

作者：

Briganti, Francesco ^{[1
]}

Leone, Giuseppe ^{[2
]}

Ugga, Lorenzo ^{[2
]}

Marseglia, Mariano ^{[1
]}

Solari, Domenico ^{[3
]}

Caranci, Ferdinando ^{[2
]}

Mariniello, Giuseppe ^{[3
]}

Maiuri, Francesco ^{[3
]}

Cappabianca, Paolo ^{[3
]}

机构：

[1] Univ Naples Federico II, Dept Adv Biomed Sci, Unit Intervent Neuroradiol, Via S Pansini 5, I-80131 Naples, Italy

[2] Federico II, Dept Adv Biomed Sci, Via S Pansini 5, I-80131 Naples, Italy

[3] Univ Naples Federico II, Div Neurosurg, Dept Neurosci Reprod & Odontostomatol Sci, Via S Pansini 5, I-80131 Naples, Italy

来源：

ACTA NEUROCHIRURGICA | 2016年 / 158卷 / 09期

关键词：

Intracranial aneurysm; Flow diverter devices; FRED; Endovascular treatment; PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; DIVERTOR DEVICES; FOLLOW-UP; INITIAL-EXPERIENCE; ENDOVASCULAR TREATMENT; SILK STENT; METAANALYSIS; MULTICENTER; DIVERSION;

D O I：

10.1007/s00701-016-2875-4

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Experience with the endovascular treatment of cerebral aneurysms by the Flow Re-Direction Endoluminal Device (FRED) is still limited. The aim of this study is to discuss the results and complications of this new flow diverter device (FDD). Between November 2013 and April 2015, 20 patients (15 female and five male) harboring 24 cerebral aneurysms were treated with FRED FDD in a single center. Complete occlusion was obtained in 20/24 aneurysms (83 %) and partial occlusion in four (17 %). Intraprocedural technical complication occurred in one case (4 %) and post-procedural complications in three (12 %). None reported neurological deficits (mRS = 0). All FRED were patent at follow-up. No early or delayed aneurysm rupture, no subarachnoid (SAH) or intraparenchymal hemorrhage (IPH) no ischemic complications and no deaths occurred. Endovascular treatment with FRED FDD is a safe treatment for unruptured cerebral aneurysms, resulting in a high rate of occlusion. The FRED is substantially equivalent to the other known FDDs, which show similar functions and technical profiles.

引用

页码：1745 / 1755

页数：11

共 50 条

[21] Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial
McDougall, Cameron G.
Diaz, Orlando
Boulos, Alan
Siddiqui, Adnan H.
Caplan, Justin
Fifi, Johanna T.
Turk, Aquilla S.
Kayan, Yasha
Jabbour, Pascal
Kim, Louis J.
Hetts, Steven W.
Cooke, Daniel L.
Dowd, Christopher F.
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2022, 14 (06) : 577 - 584
[22] North American Multicenter Experience of the Flow-Redirection Endoluminal Device (FRED) in the Treatment of Intracranial Aneurysms
Khorasanizadeh, MirHojjat
Shutran, Max
Schirmer, Clemens M.
Salem, Mohamed M.
Ringer, Andrew J.
Grandhi, Ramesh
Mitha, Alim P.
Levitt, Michael Robert
Jankowitz, Brian T.
Taussky, Phil
Thomas, Ajith J.
Moore, Justin M.
Ogilvy, Christopher S.
NEUROSURGERY, 2023, 69 : 96 - 96
[23] Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: A systematic review
Waqas, Muhammad
Dossani, Rimal H.
Alkhaldi, Modhi
Neveu, Jocelyn
Cappuzzo, Justin M.
Lim, Jaims
Khan, Asham
Lazarov, Victoria
Monteiro, Andre
Davies, Jason M.
Siddiqui, Adnan H.
Levy, Elad, I
INTERVENTIONAL NEURORADIOLOGY, 2022, 28 (03) : 347 - 357
[24] Flow Redirection Endoluminal Device (FRED) with or without Adjunctive Coiling in Treatment of Very Large and Giant Cerebral Aneurysms
Sedat Giray Kandemirli
Feyyaz Baltacioglu
Jessica Jesser
Osman Kizilkilic
Civan Islak
Markus Möhlenbruch
Naci Kocer
Clinical Neuroradiology, 2022, 32 : 471 - 480
[25] Flow Redirection Endoluminal Device (FRED) with or without Adjunctive Coiling in Treatment of Very Large and Giant Cerebral Aneurysms
Kandemirli, Sedat Giray
Baltacioglu, Feyyaz
Jesser, Jessica
Kizilkilic, Osman
Islak, Civan
Mohlenbruch, Markus
Kocer, Naci
CLINICAL NEURORADIOLOGY, 2022, 32 (02) : 471 - 480
[26] Comparison of Pipeline Embolization Device and Flow Re-Direction Endoluminal Device Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity Score-Matched Cohort Study
Griessenauer, Christoph J.
Thomas, Ajith J.
Enriquez-Marulanda, Alejandro
Deshmukh, Aviraj
Jain, Abhi
Ogilvy, Christopher S.
Kocer, Naci
Engelhorn, Tobias
Moehlenbruch, Markus
Holtmannspotter, Markus
Janssen, Hendrik
Finkenzeller, Thomas
Reith, Wolfgang
Sonnberger, Michael
Buhk, Jan-Hendrik
Schirmer, Clemens M.
Killer-Oberpfalzer, Monika
NEUROSURGERY, 2019, 85 (02) : E249 - E255
[27] Commentary: Comparison of Pipeline Embolization Device and Flow Re-Direction Endoluminal Device Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity-Score Matched Cohort Study
Bender, Matthew T.
Colby, Geoffrey P.
Coon, Alexander L.
NEUROSURGERY, 2019, 85 (02) : E256 - E257
[28] Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study
Pierot, Laurent
Spelle, Laurent
Berge, Jerome
Januel, Anne-Christine
Herbreteau, Denis
Aggour, Mohamed
Piotin, Michel
Biondi, Alessandra
Barreau, Xavier
Mounayer, Charbel
Papagiannaki, Chrisanthi
Lejeune, Jean-Paul
Gauvrit, Jean-Yves
Costalat, Vincent
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2018, 10 (08) : 765 - +
[29] Difference in the cumulative incidence of aneurysmal occlusion by Flow Re-direction Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms: a propensity score-matched cohort study
Hidetoshi Matsukawa
Kazutaka Uchida
Saujanya Rajbhandari
Manabu Shirakawa
Shinichi Yoshimura
Neurosurgical Review, 46
[30] Difference in the cumulative incidence of aneurysmal occlusion by Flow Re-direction Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms: a propensity score-matched cohort study
Matsukawa, Hidetoshi
Uchida, Kazutaka
Rajbhandari, Saujanya
Shirakawa, Manabu
Yoshimura, Shinichi
NEUROSURGICAL REVIEW, 2023, 46 (01)

← 1 2 3 4 5 →